Shlevin Harold H.
SEC Form 4 insider trading activity
Shlevin Harold H. has filed 4 SEC Form 4 filings (26 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jun 30, 2026.
On the most recent filing, Shlevin Harold H. is listed as Director at GALECTIN THERAPEUTICS INC. Inside the rolling window, Shlevin Harold H. reported no open-market purchases and 7 open-market sales totaling $1.4M in GALT. The largest disclosed transaction in the window is a sale of 139,000 GALT shares on Dec 8, 2025, worth $831K.
Companies traded
Other insiders at GALT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Shlevin Harold H. made?
Shlevin Harold H. has filed 4 SEC Form 4 filings (26 transaction rows) across 1 company since 2025.
Which companies does Shlevin Harold H. trade?
Shlevin Harold H. has filed SEC Form 4 disclosures for 1 company, including GALT.
When was Shlevin Harold H.'s most recent SEC Form 4 filing?
Shlevin Harold H.'s most recent SEC Form 4 filing on Tracefour is dated Jun 30, 2026.
What is Shlevin Harold H.'s total buy and sell value in the current window?
Inside the rolling retention window, Shlevin Harold H. bought $0 and sold $1.4M based on SEC Form 4 filings.
What was Shlevin Harold H.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 139,000 GALT shares on 2025-12-08, worth $831K, per SEC Form 4 filings.